Business and science leaders from Central Europe and Connecticut converged at the Quinnipiac University School of Law Center in Hamden (Connecticut, USA) on Friday, Jan. 27, for the day-long forum, “Building International Bridges in Life Sciences: Hungary, Poland and the Bioforum of Central Europe.” The seminar was organized by our company – Bio-Tech Consulting – together with the Quinnipiac Central European Institute, the Quinnipiac Center for Innovation and Entrepreneurship Quinnipiac University and Consulate General of Hungary in New York.
For U.S. pharmaceutical giants, Central European market, including Poland is a kind of mecca when we are talking about selling innovative biotech medicines. According to professor Pietrucha – Poland, Hungary and another countries of Central Europe have to actively seek to change the current business model of these companies in relations to our region. We would like to change that model only to ”seller – customer”. We want to co–create new products, through our innovative companies. Moreover, we want to be not only good customers but also co-creators of these products together with our American partners.
Christopher Ball, director of the Central European Institute, said the goal of the event was: to build wider cooperation between Central European and U.S. companies and investors.
Over 100 entrepreneurs and scientists who attended the forum had an opportunity to watch presentations by Polish, Hungarian and select U.S. companies, and learn about life science and innovations in Central Europe, private and public research, development funding and the European biomarket.
Furthermore, our company released brochure ”Spotlight on Polish life science” to intrigue USA and pass the information about Polish market.
What is more interesting, it is not the end of the event. It will be continued in May in Łódź.